Drug that can halve breast cancer risk offered to 289,000 women in England

Millions of Women Feel Severe Pain From This Condition. Why Don't We Talk About It?

Miss England 'flies' Boeing Starliner spaceship at NASA's Kennedy Space Center

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.